Literature DB >> 7431682

Comparative studies on absorption patterns of the drug after intrarectal administration of 5-FU emulsion and 5-FU solution.

S Watanabe, B Nishioka, Y Fujita, T Ueda, O Kojima, K Morisawa, E Yamane, M Umehara, S Majima.   

Abstract

Intrarectal administration of 5-fluorouracil (5-FU) emulsion was compared experimentally with that of 5-FU solution as to the degree of absorption and tissue distribution. For the 5-FU levels in the rectal wall, the levels in the emulsion group remained at high levels during the 6 hour period after administration while the levels in the solution group decreased rapidly. For the 5-FU levels in the lymph nodes, those in the emulsion group were significantly higher (more than four times) and remained at relatively high levels for a longer period than those in the solution group. In the thoracic lymph, 5-FU levels in the emulsion group remained more than two times higher throughout the experimental period. The results suggest tha preoperative intrarectal administration of 5-FU emulsion may be effective as an adjunct to surgery for rectal cancer with lymph node metastasis, because of the long duration of high concentration resulting in the rectal lymphatics and rectal wall.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7431682     DOI: 10.1007/bf02468673

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  11 in total

1.  Five years clinical experience with 5-fluorouracil.

Authors:  F J ANSFIELD; J M SCHROEDER; A R CURRERI
Journal:  JAMA       Date:  1962-07-28       Impact factor: 56.272

2.  Intraluminal fluorouracil chemotherapy adjunct to surgical procedures for respectable carcinoma of the colon and rectum.

Authors:  C E Grossi; W I Wolff; T F Nealon; B Pasternack; L Ginzburg; L M Rousselot
Journal:  Surg Gynecol Obstet       Date:  1977-10

3.  Increased concentration of anticancer agents in regional lymph nodes by fat emulsions, with special reference to chemotherapy of metastasis.

Authors:  T Takahashi; M Mizuno; Y Fujita; S Ueda; B Nishioka
Journal:  Gan       Date:  1973-08

4.  Adjuvant chemotherapy with 5-fluorouracil in surgery for colorectal cancer: eight-year progress report.

Authors:  L M Rousselot; D R Cole; C E Grossi; A J Conte; E M Gonzalez; B S Pasternack
Journal:  Dis Colon Rectum       Date:  1972 May-Jun       Impact factor: 4.585

5.  Effects of 5-fluorouracil (NSC-19893) in 389 patients with cancer. Eastern Clinical Drug Evaluation Program.

Authors:  G E Moore; I D Bross; R Ausmans; S Nadler; R Jones; N Slack; A A Rimm
Journal:  Cancer Chemother Rep       Date:  1968-10

6.  Intraluminal chemotherapy (HN2 or 5-FU) adjuvant to operation for cancer of the colon and rectum. II. Follow-up report of 97 cases.

Authors:  L M Rousselot; D R Cole; C E Grossi; A J Conte; E M Gonzalez
Journal:  Cancer       Date:  1967-05       Impact factor: 6.860

7.  Clinical and experimental studies of oral 5-FU emulsion as an adjuvant to the surgical treatment of gastric cancer.

Authors:  B Nishioka; S Watanabe; Y Fujita; S Majima; T Takahashi
Journal:  World J Surg       Date:  1978-07       Impact factor: 3.352

8.  Basic experiments on oral administration of 5-fluorouracil emulsion as adjuvant chemotherapy to surgical treatment for gastric cancer.

Authors:  S Watanabe; E Nakao; K Cho; B Nishioka; Y Fujita; T Takahashi; S Majima
Journal:  Jpn J Surg       Date:  1978-03

9.  Histological evaluation of the effect of 5-FU emulsion on lymph node metastasis of stomach cancer.

Authors:  S Majima; S Watanabe; E Nakao; T Ueda; K Morisawa; K Cho; B Nishioka; Y Fujita; T Takahashi
Journal:  Jpn J Surg       Date:  1978-06

10.  Attempt at local administration of anticancer agents in the form of fat emulsion.

Authors:  T Takahashi; S Ueda; K Kono; S Majima
Journal:  Cancer       Date:  1976-10       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.